Xuanfu Xu
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 2
- Hepatology top 10%
-
- Genetic factors in colorectal cancer 3
- Cancer Mechanisms and Therapy 2
-
- Liver Disease Diagnosis and Treatment 3
- Neuroendocrine Tumor Research Advances 2
-
- Sirtuins and Resveratrol in Medicine 2
In The Last Decade
Xuanfu Xu
24 papers receiving 818 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 243
- Hepatology 63
- Molecular Biology 470
- Oncology 186
- Pathology and Forensic Medicine 83
Countries citing papers authored by Xuanfu Xu
This map shows the geographic impact of Xuanfu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuanfu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuanfu Xu more than expected).
Fields of papers citing papers by Xuanfu Xu
This network shows the impact of papers produced by Xuanfu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuanfu Xu. The network helps show where Xuanfu Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuanfu Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 9 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 13 | |
| 5 | 2021 | 0 | |
| 6 | 2020 | 169 | |
| 7 | 2020 | 26 | |
| 8 | 2017 | 16 | |
| 9 | 2014 | 5 | |
| 10 | 2013 | 76 | |
| 11 | 2013 | 37 | |
| 12 | 2012 | 101 | |
| 13 | 2012 | 24 | |
| 14 | 2011 | 5 | |
| 15 | 2010 | 10 | |
| 16 | 2010 | 43 | |
| 17 | 2009 | 10 | |
| 18 | 2008 | 19 | |
| 19 | 2008 | 18 | |
| 20 | Peroxisome proliferator activated receptor γ (PPARγ) is aberrantly expressed in pancreatic carcinoma | 2002 | 1 |
About Xuanfu Xu
Xuanfu Xu is a scholar working on Geriatrics and Gerontology, Cancer Research and Gastroenterology, having authored 25 papers that have together received 820 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Genetic factors in colorectal cancer (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Mechanisms and Therapy (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Cancer Research (243 citations), Hepatology (63 citations) and Molecular Biology (470 citations). Xuanfu Xu has collaborated with scholars based in China, India and Japan. Frequent co-authors include Chuanyong Guo, Weiqi Dai, Wenhui Mo, Ling Xu, Jianye Wu, Jingjing Li, Jiao Feng, Liwei Wu, Qiang Yu and Kan Chen. Their work appears in journals such as PLoS ONE, British Journal of Pharmacology and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.